NASDAQ:WVE

Wave Life Sciences Stock Insider Trading

Healthcare > Biotechnology

Buy WVE

*Your capital is at risk

$5.76

+0.0700 (+1.23%)

At Close: Jun 03, 2026

WAVE Life Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 72.72. In total, the insiders bought 19.58M and sold 4.78M WVE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	72.72
● Buy	19.58M shares
● Sell	4.78M shares
67% Buy Activity Negligible or No Correlation
Buy Signal Medium Confidence Mar 26, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 72.72. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 09, 2026 Buy	Share Option (Right to Buy)	Wright Christopher I Chief Medical Officer	Officer	300 000 Value: $1.78M
Apr 09, 2026 Buy	Ordinary Shares	Wright Christopher I Chief Medical Officer	Officer	0 Value: $0
Apr 09, 2026 Buy	Share Option (Right to Buy)	Ingelsson Erik Chief Scientific Officer	Officer	200 000 Value: $2.35M
Apr 09, 2026 Buy	Ordinary Shares	Ingelsson Erik Chief Scientific Officer	Officer	0 Value: $0
Apr 09, 2026 Buy	Share Option (Right to Buy)	Wright Christopher I Chief Medical Officer	Officer	273 750 Value: $3.49M
Apr 09, 2026 Buy	Share Option (Right to Buy)	Ingelsson Erik Chief Scientific Officer	Officer	273 750 Value: $3.49M
Apr 09, 2026 Buy	Share Option (Right to Buy)	Ingelsson Erik Chief Scientific Officer	Officer	350 000 Value: $2.05M
Mar 30, 2026 Buy	Ordinary Shares P-Purchase	Ra Capital Management, L.p.	Director	971 091 Value: $6.31M
Mar 27, 2026 Buy	Ordinary Shares P-Purchase	Ra Capital Management, L.p.	Director	2 495 623 Value: $16.0M
Mar 26, 2026 Buy	Ordinary Shares P-Purchase	Ra Capital Management, L.p.	Director	351 224 Value: $2.24M
Mar 26, 2026 Buy	Ordinary Shares P-Purchase	Ra Capital Management, L.p.	Director	4 954 558 Value: $30.0M
Mar 23, 2026 Sell	Series A Preferred Shares C-Conversion	Takanashi Ken Director	Director	3 901 348 Value: $0
Mar 23, 2026 Buy	Ordinary Shares C-Conversion	Takanashi Ken Director	Director	3 901 348 Value: $45.3M
Feb 26, 2026 Sell	Ordinary Shares S-Sale	Francis Chris See Remarks	Officer	17 900 Value: $270.2K
Feb 26, 2026 Buy	Ordinary Shares M-Exempt	Francis Chris See Remarks	Officer	15 294 Value: $72.6K
Feb 26, 2026 Buy	Ordinary Shares M-Exempt	Francis Chris See Remarks	Officer	17 900 Value: $69.3K
Feb 26, 2026 Buy	Share Option (right to buy) M-Exempt	Francis Chris See Remarks	Officer	17 900 Value: $69.3K
Feb 26, 2026 Sell	Ordinary Shares S-Sale	Francis Chris See Remarks	Officer	15 294 Value: $229.4K
Feb 26, 2026 Buy	Share Option (right to buy) M-Exempt	Francis Chris See Remarks	Officer	15 294 Value: $72.6K
Feb 09, 2026 Sell	Ordinary Shares S-Sale	Moran Kyle Chief Financial Officer	C-Suite Officer	3 588 Value: $48.3K
Feb 09, 2026 Sell	Ordinary Shares S-Sale	Bolno Paul President And CEO	CEO / President	10 480 Value: $141.0K
Feb 09, 2026 Sell	Ordinary Shares S-Sale	Francis Chris See Remarks	Officer	1 883 Value: $25.3K
Feb 09, 2026 Sell	Ordinary Shares S-Sale	Vargeese Chandra See Remarks	Officer	3 228 Value: $43.4K
Feb 05, 2026 Buy	Share Option (right to buy) A-Award	Vargeese Chandra See Remarks	Officer	273 750 Value: $3.49M
Feb 05, 2026 Buy	Ordinary Shares A-Award	Vargeese Chandra See Remarks	Officer	45 625 Value: $581.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT WAVE LIFE SCIENCES LTD.

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company also develops WVE-004, a C9orf72 molecule for the t...

Read Full Profile Here